Eric Ostertag, Chief Executive Officer, 10% Owner at Poseida Therapeutics, Inc. (PSTX), sold 4,462 shares at $10.00 ($45K) on 2021-01-21, disclosed to the SEC on 2021-01-25.
Scheduled sale ($45k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |